GlassScriptPhysician profile
Alice M Phillips
NPI 1336111327
$1,215.01
in general payments reported to CMS, 2019-2025
20 companies · $432 in 2025
The $432 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $81.50 · 2023: $200 · 2024: $501 · 2025: $432.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,133.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $165.71 | 2022-2024 | Shingrix, Arexvy, Bexsero |
| Lilly USA, LLC | $161.08 | 2024 | Mounjaro, Zepbound, Trulicity |
| Exact Sciences Corporation | $121.13 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Novo Nordisk INC | $119.95 | 2023-2025 | Ozempic, Rybelsus |
| Pfizer INC. | $114.69 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $93.95 | 2022-2025 | Jardiance |
| Abbvie INC. | $74.10 | 2024-2025 | |
| Amgen INC. | $58.73 | 2025 | Repatha, Otezla |
| Corcept Therapeutics | $46.62 | 2025 | Korlym |
| Smith+Nephew, INC. | $37.99 | 2024 | Renasys, Acticoat 4" X 4" |
| Mayne Pharma Commercial LLC | $29.92 | 2025 | |
| Janssen Pharmaceuticals, INC | $26.67 | 2025 | Spravato |
| Aimmune Therapeutics, INC. | $26.22 | 2025 | Zenpep |
| Medtronic, INC. | $26.08 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.62 | 2024 | Xifaxan |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $20.97 | 2023 | Opsumit, Uptravi |
| Philips North America LLC | $20.33 | 2024 | (Ak6) Vest Therapy |
| Electromed, INC. | $19.44 | 2025 | Smartvest |
| Astrazeneca Pharmaceuticals LP | $17.25 | 2023 | Farxiga |
| Phathom Pharmaceuticals, INC. | $11.56 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alice Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.